DeepMed Research

Shanghai Jiaotong Medical University Attached Ruijin Hospital

🇨🇳China

Country: 🇨🇳China

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Unexpected Pharmacokinetics of Vancomycin in Patients With Severe Acute Pancreatitis Compared With Pneumonia

Conditions: Arbitrary Restriction Polymorphism 1

First Posted Date: 2014-05-09

Last Posted Date: 2014-05-09

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 200

Registration Number: NCT02134665

Locations: 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China

Effects of Early Stage Mini-invasive Abdominal Drainage on Complications and Prognosis of SAP

Not Applicable

Conditions: Pancreatitis

Interventions: Other: Late stage abdominal drainage
Other: Early stage abdominal drainage

First Posted Date: 2013-12-06

Last Posted Date: 2013-12-06

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 40

Registration Number: NCT02002793

Locations: 🇨🇳
Ruijin, Shanghai, Shanghai, China

Early Enteral Nutrition in Severe Acute Pancreatitis

Not Applicable

Conditions: Pancreatitis

Interventions: Other: early enteral nutrition
Other: modified early enteral nutrition

First Posted Date: 2013-12-04

Last Posted Date: 2013-12-04

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 60

Registration Number: NCT02000323

Locations: 🇨🇳
Ruijin, Shanghai, Shanghai, China

Continuous Blood Purification for Regulation of Early Inflammatory Response In Severe Acute Pancreatitis

Not Applicable

Conditions: Acute Pancreatitis

Interventions: Other: CVVH 10h
Other: CVVH 6h
Other: CVVHDF 6h

First Posted Date: 2013-11-28

Last Posted Date: 2013-11-28

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 30

Registration Number: NCT01998334

Locations: 🇨🇳
Department of EICU, Ruijin Hospital,, Shanghai, Shanghai, China

Effect of Early Mechanical Ventilation to Severe Acute Pancreatitis

Not Applicable

Conditions: Acute Pancreatitis
Complication of Ventilation Therapy

Interventions: Other: early mechanical Ventilation
Other: Conventional Mechanical Ventilation

First Posted Date: 2013-11-25

Last Posted Date: 2013-11-25

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 2

Registration Number: NCT01992224

Locations: 🇨🇳
Department of EICU, Ruijin Hospital, Shanghai, China

Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis

Not Applicable

Conditions: Pancreatitis

Interventions: Other: Goal A
Other: Goal B

First Posted Date: 2013-11-01

Last Posted Date: 2013-11-19

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 60

Registration Number: NCT01974466

Locations: 🇨🇳
Ruijin, Shanghai, Shanghai, China

A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy

Phase 4

Conditions: Graves' Ophthalmopathy

Interventions: Drug: methylprednisolone, prednisone

First Posted Date: 2013-10-24

Last Posted Date: 2013-10-24

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 70

Registration Number: NCT01969019

Locations: 🇨🇳
Shanghai Institute of Endocrine and Metabolic Diseases Department of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai, Shanghai, China

R-CEOP-90/R-CEOP-70 Versus R-CHOP-50 in the Treatment of Diffuse Large B-cell Lymphoma and Follicular Lymphoma Grade 3B

Phase 3

Conditions: Diffuse Large B-cell Lymphoma
Follicular Lymphoma Grade 3B

Interventions: Drug: R-CEOP-90
Drug: R-CEOP-70
Drug: R-CHOP-50

First Posted Date: 2013-05-13

Last Posted Date: 2017-11-14

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 648

Registration Number: NCT01852435

Locations: 🇨🇳
Guangdong General Hospital, Guangzhou, Guangdong, China
🇨🇳
Henan Cancer Hospital, Zhengzhou, Henan, China
🇨🇳
Tongji Hospital, Wuhan, Hubei, China

and more 9 locations

Effects of Bisoprolol and Atenolol on Sympathetic Nervous Activity and Central Aortic Pressure in Patients With Essential Hypertension

Phase 4

Completed

Conditions: Untreated Essential Hypertension

Interventions: Drug: bisoprolol
Drug: atenolol

First Posted Date: 2013-01-07

Last Posted Date: 2013-01-08

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 109

Registration Number: NCT01762436

Locations: 🇨🇳
State Key Laboratory of Medical Genomics, Shanghai Key Laboratory of Hypertension and Department of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China

CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma

Phase 4

Conditions: ALK-negative Anaplastic Large Cell Lymphoma
Peripherial T Cell Lymphoma,Not Otherwise Specified
Angioimmunoblastic T Cell Lymphoma
Enteropathy Associated T Cell Lymphoma
Hepatosplenic T Cell Lymphoma
Subcutaneous Panniculitis Like T Cell Lymphoma

Interventions: Drug: Cyclophosphamide 750mg/m2
Drug: Vincristine 1.4mg/m2
Drug: Doxorubicin 50mg/m2
Drug: prednisone 60mg/m2
Drug: ifosfamide 2000mg/m2
Drug: pirarubicin 50mg/m2
Drug: pirarubicin 25mg/m2
Drug: Etoposide phosphate 100mg/m2
Drug: methotrexate 1500mg/m2

First Posted Date: 2012-12-11

Last Posted Date: 2017-11-14

Lead Sponsor: Ruijin Hospital

Target Recruit Count: 200

Registration Number: NCT01746992

Locations: 🇨🇳
Ruijin hospital, Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy